ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirklin, J. W.
Right arrow Articles by Stewart, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirklin, J. W.
Right arrow Articles by Stewart, R. W.

The Annals of Thoracic Surgery, Vol 44, 598-606, Copyright © 1987 by The Society of Thoracic Surgeons

ARTICLES

Intermediate-term fate of cryopreserved allograft and xenograft valved conduits

JW Kirklin, EH Blackstone, T Maehara, AD Pacifico, JK Kirklin, S Pollock and RW Stewart
Department of Surgery, University of Alabama at Birmingham Medical Center.

Actuarial freedom from reoperation for obstruction in 147 patients receiving cryopreserved or fresh allograft valved conduits between a ventricle and the pulmonary arteries was 94% at 3.5 years. The 2 patients undergoing reoperation were 6 and 36 months of age at the time of insertion of the allograft. Among 24 patients in whom cardiac catheterization was performed on indication late postoperatively, 5 had gradients of more than 40 mm Hg across the conduit. For comparison, among 78 patients receiving xenograft or irradiated allograft valved conduits, the percentages of freedom from conduit reoperation at 3.5, 5, 10, and 15 years were 99%, 95%, 59%, and 11%, respectively. The diameters of the allograft and xenograft valves inserted varied directly with the age and size of the patients, but in patients 3 to 5 years of age, allografts with a diameter of at least 21 mm could usually be used.


This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
E. S. Selamet Tierney, W. M. Gersony, K. Altmann, D. E. Solowiejczyk, L. M. Bevilacqua, C. Khan, E. Krongrad, R. S. Mosca, J. M. Quaegebeur, and H. D. Apfel
Pulmonary position cryopreserved homografts: Durability in pediatric Ross and non-Ross patients
J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 282 - 286.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
H. Javadpour, D. Veerasingam, and A.E. Wood
Calcification of homograft valves in the pulmonary circulation -- is it device or donation related?
Eur. J. Cardiothorac. Surg., July 1, 2002; 22(1): 78 - 81.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
P. Bonhoeffer, Y. Boudjemline, S. A. Qureshi, J. Le Bidois, L. Iserin, P. Acar, J. Merckx, J. Kachaner, and D. Sidi
Percutaneous insertion of the pulmonary valve
J. Am. Coll. Cardiol., May 15, 2002; 39(10): 1664 - 1669.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
S. Conte, R. Jashari, B. Eyskens, M. Gewillig, M. Dumoulin, and W. Daenen
Homograft valve insertion for pulmonary regurgitation late after valveless repair of right ventricular outflow tract obstruction
Eur. J. Cardiothorac. Surg., February 1, 1999; 15(2): 143 - 149.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. Niwaya, C. J. Knott-Craig, M. M. Lane, K. Chandrasekaren, E. D. Overholt, and R. C. Elkins
CRYOPRESERVED HOMOGRAFT VALVES IN THE PULMONARY POSITION: RISK ANALYSIS FOR INTERMEDIATE-TERM FAILURE
J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 141 - 147.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
J. Robin, S. Martinot, A. Curtil, C. Vedrinne, F. Tronc, M. Franck, and G. Champsaur
Experimental right ventricle to pulmonary artery discontinuity: Outcome of polyurethane valved conduits
J. Thorac. Cardiovasc. Surg., April 1, 1998; 115(4): 898 - 903.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S. Nakae, S. Kasahara, N. Kuroyama, Z.-B. Lin, S. Hiraishi, Y. Agata, and H. Yoshimura
Correction of Truncus Arteriosus With Autologous Arterial Flap in Neonates and Small Infants
Ann. Thorac. Surg., July 1, 1996; 62(1): 123 - 128.
[Abstract] [Full Text]

Home page
 CirculationHome page
A. J. Powell, J. E. Lock, J. F. Keane, and S. B. Perry
Prolongation of RV-PA Conduit Life Span by Percutaneous Stent Implantation : Intermediate-Term Results
Circulation, December 1, 1995; 92(11): 3282 - 3288.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
K. Tamura, M. Jones, I. Yamada, and V. J. Ferrans
A comparison of failure modes of glutaraldehyde-treated versus antibiotic-preserved mitral valve allografts implanted in sheep
J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 224 - 238.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
M. Ando, Y. Imai, S. Hoshino, and K. Ishihara
Autologous Reconstruction of Pulmonary Trunk at Reoperation After Extracardiac Conduit Repair
Ann. Thorac. Surg., March 1, 1995; 59(3): 621 - 625.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
M. A. Salim, T. G. DiSessa, B. S. Alpert, K. L. Arheart, W. M. Novick, and D. C. Watson Jr
The Fate of Homograft Conduits in Children With Congenital Heart Disease: An Angiographic Study
Ann. Thorac. Surg., January 1, 1995; 59(1): 67 - 73.
[Abstract] [Full Text]

Home page
 VASC ENDOVASCULAR SURGHome page
T. Sarioglu, T. Paker, A. Sarioglu, O. Bayindir, A. Koner, and A. Aytac
Use of Non-Valved Extracardiac Conduits in Complex Congenital Anomalies
Vascular and Endovascular Surgery, November 1, 1991; 25(9): 702 - 707.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1987 by The Society of Thoracic Surgeons.